InvestorsHub Logo
Followers 1739
Posts 142128
Boards Moderated 4
Alias Born 09/11/2005

Re: lasers post# 30088

Saturday, 10/06/2012 8:04:13 AM

Saturday, October 06, 2012 8:04:13 AM

Post# of 401510
FDA-APPROVAL-HAS-BEEN-GIVEN-Naltrexone-Phendimetrazine-Phentermine-15mg-30mg-capsules

Elite states verbally to those that call, that the FDA approval has been given for (1) the product transfer for Naltrexone (2) the product transfer for Phendimetrazine and (3) the new ANDA Phentermine 15mg, 30mg capsules. Elite states further that to be legally correct, they are waiting for the imminent FDA official documentation to affirm in print and update their Product Pipeline website. Elite will confirm verbally to those that call.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=80273527


CONTACT: For Elite Pharmaceuticals, Inc.
Dianne Will, Investor Relations, 518-398-6222
Dianne@elitepharma.com
www.elitepharma.com


Thanks lasers... these are the next 2 products we were waiting on for approval, and the new phentermine is a BONUS.

Now we know that this current quarter starting in October will show big revenue boosts, probably near cash flow positive!

And there are still so many more products near approval, and in later stages of development.

All this for .11..... no I don't think there will be any more .11's.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News